URINARY BETA-2-MICROGLOBULIN - EARLY INDICATOR OF HIGH-DOSE CISDIAMMINEDICHLOROPLATINUM NEPHROTOXICITY - INFLUENCE OF FUROSEMIDE

被引：12

作者：

DEGISLAIN, C

DUMAS, M

DATHIS, P

LAUTISSIER, JL

ESCOUSSE, A

GUERRIN, J

机构：

[1] HOP GEN DIJON,DEPT PHARMACOL CLIN,DIJON,FRANCE

[2] HOP BOCAGE,DEPT INFORMAT MED,F-21000 DIJON,FRANCE

来源：

关键词：

D O I：

10.1007/BF00273402

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：276 / 279

页数：4

共 19 条

[1] GENTAMICIN IN 1978
APPEL, GB
NEU, HC
[J]. ANNALS OF INTERNAL MEDICINE, 1978, 89 (04) : 528 - 538
[2] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN
BLACHLEY, JD
HILL, JB
[J]. ANNALS OF INTERNAL MEDICINE, 1981, 95 (05) : 628 - 632
[3] COHEN AI, 1981, CANCER TREAT REP, V65, P1083
[4] BETA-2-MICROGLOBULIN REVIEW - ITS RELEVANCE IN CLINICAL ONCOLOGY
COOPER, EH
PLESNER, T
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1980, 8 (04): : 323 - 334
[5] DUMAS M, 1985, J CLIN PHARM THER TO, V23, P40
[6] CISPLATIN NEPHROTOXICITY - A SUMMARY OF PREVENTATIVE INTERVENTIONS
FINLEY, RS
FORTNER, CL
GROVE, WR
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (05): : 362 - 367
[7] GONZALEZVITALE JC, 1977, CANCER, V39, P1362, DOI 10.1002/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO
[8] 2-N
[9] COMPARISON OF METHODS OF EVALUATING NEPHROTOXICITY OF CIS-PLATINUM
JONES, BR
BHALLA, RB
MLADEK, J
KALEYA, RN
GRALLA, RJ
ALCOCK, NW
SCHWARTZ, MK
YOUNG, CW
REIDENBERG, MM
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 557 - 562
[10] KARNOFSKY DA, 1968, P INT C LEUKEMIA LYM, V1, P409